451 related articles for article (PubMed ID: 24262754)
1. Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing.
Zhou Q; Chung AC; Huang XR; Dong Y; Yu X; Lan HY
Am J Pathol; 2014 Feb; 184(2):409-17. PubMed ID: 24262754
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA
Wang P; Luo ML; Song E; Zhou Z; Ma T; Wang J; Jia N; Wang G; Nie S; Liu Y; Hou F
Sci Transl Med; 2018 Oct; 10(462):. PubMed ID: 30305452
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA Arid2-IR Is a Novel Therapeutic Target for Renal Inflammation.
Zhou Q; Huang XR; Yu J; Yu X; Lan HY
Mol Ther; 2015 Jun; 23(6):1034-1043. PubMed ID: 25743111
[TBL] [Abstract][Full Text] [Related]
4. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
5. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L
Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895
[TBL] [Abstract][Full Text] [Related]
6. LncRNA GAS5 protects against TGF-β-induced renal fibrosis via the Smad3/miRNA-142-5p axis.
Zhang YY; Tan RZ; Yu Y; Niu YY; Yu C
Am J Physiol Renal Physiol; 2021 Oct; 321(4):F517-F526. PubMed ID: 34486400
[TBL] [Abstract][Full Text] [Related]
7. Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling.
You YK; Luo Q; Wu WF; Zhang JJ; Zhu HJ; Lao L; Lan HY; Chen HY; Cheng YX
J Cell Mol Med; 2019 Aug; 23(8):5576-5587. PubMed ID: 31211499
[TBL] [Abstract][Full Text] [Related]
8. TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis.
Feng M; Tang PM; Huang XR; Sun SF; You YK; Xiao J; Lv LL; Xu AP; Lan HY
Mol Ther; 2018 Jan; 26(1):148-161. PubMed ID: 29102563
[TBL] [Abstract][Full Text] [Related]
9. Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction.
Inazaki K; Kanamaru Y; Kojima Y; Sueyoshi N; Okumura K; Kaneko K; Yamashiro Y; Ogawa H; Nakao A
Kidney Int; 2004 Aug; 66(2):597-604. PubMed ID: 15253712
[TBL] [Abstract][Full Text] [Related]
10. Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling.
Jung KJ; Kim J; Park YK; Yoon YR; Park KM
Food Chem Toxicol; 2010 Feb; 48(2):522-9. PubMed ID: 19913069
[TBL] [Abstract][Full Text] [Related]
11. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
[TBL] [Abstract][Full Text] [Related]
12. Identification of Genes Associated with Smad3-dependent Renal Injury by RNA-seq-based Transcriptome Analysis.
Zhou Q; Xiong Y; Huang XR; Tang P; Yu X; Lan HY
Sci Rep; 2015 Dec; 5():17901. PubMed ID: 26648110
[TBL] [Abstract][Full Text] [Related]
13. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.
Li R; Chung AC; Dong Y; Yang W; Zhong X; Lan HY
Kidney Int; 2013 Dec; 84(6):1129-44. PubMed ID: 23868013
[TBL] [Abstract][Full Text] [Related]
14. Oxymatrine inhibits renal fibrosis of obstructive nephropathy by downregulating the TGF-β1-Smad3 pathway.
Wang HW; Shi L; Xu YP; Qin XY; Wang QZ
Ren Fail; 2016 Jul; 38(6):945-51. PubMed ID: 27050799
[TBL] [Abstract][Full Text] [Related]
15. The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling.
Zhang Y; Meng XM; Huang XR; Lan HY
Clin Sci (Lond); 2018 Jul; 132(13):1403-1415. PubMed ID: 29875262
[TBL] [Abstract][Full Text] [Related]
16. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chung AC; Qin W; Chen HY; Lan HY
Kidney Int; 2012 Feb; 81(3):266-79. PubMed ID: 22048127
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction.
Liang J; Tian S; Han J; Xiong P
Ren Fail; 2014 Mar; 36(2):285-91. PubMed ID: 24152192
[TBL] [Abstract][Full Text] [Related]
18. Smad3 mediates ANG II-induced hypertensive kidney disease in mice.
Liu Z; Huang XR; Lan HY
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F986-97. PubMed ID: 22237801
[TBL] [Abstract][Full Text] [Related]
19. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in
Sun SF; Tang PMK; Feng M; Xiao J; Huang XR; Li P; Ma RCW; Lan HY
Diabetes; 2018 Apr; 67(4):731-744. PubMed ID: 29222368
[TBL] [Abstract][Full Text] [Related]
20. SMAD3-dependent and -independent pathways in glomerular injury associated with experimental glomerulonephritis.
Ghayur A; Padwal MK; Liu L; Zhang J; Margetts PJ
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F152-F162. PubMed ID: 31141397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
